Bloomberg Law
Health Law & Business News

Nursing Homes, HHS on Collision Path Over Staffing Mandate

The Biden administration’s push to improve nursing home care through better staffing—and the industry’s insistence that it needs more workers and funding to make it happen—could set the stage for intervention by Congress or the courts.

Emergency Abortion Clash at Supreme Court Tests Strictest Bans

The US Supreme Court will consider just how far states can go in prohibiting abortion Wednesday as it weighs whether emergency room doctors nationwide can perform the procedure when a pregnant woman’s health is at serious risk.

Biden’s HHS Toughens Federal Nursing Home Staffing Mandate

The common practice by private equity firms of buying hospitals only to sell off the real estate and lease it back to the facility raises potential competition concerns, <-bsp-bb-link state="{"bbHref":"bbg://securities/13362Z%20US%20Equity","_id":"0000018f-0bd9-d583-afbf-cbddad4c0000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Federal Trade Commission Chair <-bsp-person state="{"_id":"0000018f-0bd9-d583-afbf-cbddad4c0001","_type":"00000160-6f41-dae1-adf0-6ff519590003"}">Lina Khan said Tuesday.

Wegovy Access Expands to Millions in US on Medicare, Study Finds

Medicare’s recent decision to cover Novo Nordisk A/S’s blockbuster obesity shot Wegovy for heart disease will possibly subsidize the drug for some 3.6 million people, according to a new study from Kaiser Family Foundation.

Union Health Fund Sues Insulin Makers, PBMs on Price Conspiracy

A Connecticut health benefits fund accused major insulin manufacturers and pharmacy benefit managers of engaging in a widespread deceptive pricing scheme that caused the fund to overpay for diabetes medications.

Latest Stories

GSK’s ViiV, Exavir Settle Suit on HIV-Drug Compounds Licensing

ViiV Healthcare and Exavir Therapeutics ended a lawsuit over allegations that Exavir’s patent-licensing agreement with the University of Nebraska on long-acting HIV therapy compounds interfered with the GlaxoSmithKline unit’s research collaboration with the university.

Pharma Startup Uses AI to Test Old Drugs to Treat Rare Diseases

For the past six years, Carrie Rich has been on a journey no parent wants to take. Her daughter has a form of autism caused by a rare genetic condition, and Rich is desperate to help her combat the effects of the genetic anomaly. They’ve left the girl unable to speak and blunted her ability to move and interact like her 7-year-old peers. “I’ve spoken with researchers, scientists, academics, entrepreneurs, philanthropists, investors and parents across the planet,” Rich says. “I mean, truly anyone who would speak with me. I was really hoping to find someone who could lead me in a positive direction forward.”

Nursing Homes, HHS on Collision Path Over Staffing Mandate

The Biden administration’s push to improve nursing home care through better staffing—and the industry’s insistence that it needs more workers and funding to make it happen—could set the stage for intervention by Congress or the courts.

Beyond Abortion: The Fight Over Fetal Personhood Is Here

When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.

From Across Bloomberg Law

Business & Practice Environment & Energy Report Environmental, Social & Governance (ESG) The United States Law Week
  • Business & Practice
  • Environment & Energy Report
  • Environmental, Social & Governance (ESG)
  • The United States Law Week

Supreme Court Today, April 25, 2024

Supreme Court Today, Vol. 92 No. 40, pages 3275-3286, dated April 25, 2024, is now available. A link to the PDF version can be found in the Related Documents field.

Microsoft, Amazon AI Deals Get UK Antitrust Scrutiny (2)

Amazon.com Inc. and Microsoft Corp.’s investments into artificial intelligence startups will get deeper scrutiny from the UK’s antitrust watchdog, the latest example of how global regulators are grappling with how the world’s largest technology firms are influencing the booming market.

Google’s Pichai Has No Time for an Employee Rebellion: Dave Lee

Chief Executive Officer Sundar Pichai’s recent memo to workers, sent amid the latest round of discontent at the company — this time over the company’s $1.2 billion contract (shared with Amazon.com Inc.) to provide cloud services to Israel. By Tuesday, at least 50 employees had been fired for involvement in several protests at Google’s offices.

Covid Vaccine & Personal Data: Does HIPAA Still Matter?